Dallas Logo
File #: 21-2314    Version: 1 Name:
Type: ITEMS FOR INDIVIDUAL CONSIDERATION Status: Approved
File created: 11/24/2021 In control: City Attorney's Office
On agenda: 12/8/2021 Final action:
Title: Authorize settlements with opioid manufacturer, Johnson & Johnson, and the three major pharmaceutical distributors: AmerisourceBergen, Cardinal Health, and McKesson - Financing: No cost consideration to the City
Indexes: 300
Attachments: 1. Resolution, 2. Exhibit A
Date Ver.Action ByActionResultAction DetailsMeeting DetailsVideo
No records to display.

STRATEGIC PRIORITY:                     Government Performance and Financial Management

AGENDA DATE:                     December 8, 2021

COUNCIL DISTRICT(S):                     N/A

DEPARTMENT:                     City Attorney’s Office

EXECUTIVE:                     Christopher J. Caso

______________________________________________________________________

SUBJECT

 

title

Authorize settlements with opioid manufacturer, Johnson & Johnson, and the three major pharmaceutical distributors: AmerisourceBergen, Cardinal Health, and McKesson - Financing:  No cost consideration to the City

 

body

BACKGROUND

 

On November 9, 2021, the Council Government Performance and Financial Management Committee was briefed by the Office of the Attorney General and Larry Taylor, Esq. on the proposed settlements with opioid manufacturer, Johnson & Johnson, and the three major pharmaceutical distributors: AmerisourceBergen, Cardinal Health, and McKesson.

 

PRIOR ACTION/REVIEW (COUNCIL, BOARDS, COMMISSIONS)

 

A confidential memorandum regarding this matter was provided to the City Council on December 3, 2021.

 

FISCAL INFORMATION

 

No cost consideration to the City. Depending upon the outcome of the settlement, the City may receive revenue.